Hana Shpilt

Affiliations

Gilboa Therapeutics Ltd., Rehovot, Israel.

ORCID: 0000-0003-1334-4972

Publications (1)

T Cells Expressing a Modified FcγRI Exert Antibody-Dependent Cytotoxicity and Overcome the Limitations of CAR T-cell Therapy against Solid Tumors.

Cancer immunology research

Avec: Diana Rasoulouniriana , Nadine Santana-Magal , Amit Gutwillig , Leen Farhat-Younis , Lior Tal , Sarah Amar , Michael Milyavsky , Siva Sai Naga Anurag Muddineni , Neta Solomon , Hana Shpilt , Shahar Dotan , Noam Pilpel , Claudia Waskow , Meora Feinmesser , Peleg Rider , Yaron Carmi

Réseau de co-auteurs

Diana Rasoulouniriana 1 collaboration

Nadine Santana-Magal 1 collaboration

Amit Gutwillig 1 collaboration

Leen Farhat-Younis 1 collaboration

Lior Tal 1 collaboration

Sarah Amar 1 collaboration

Michael Milyavsky 1 collaboration

Siva Sai Naga Anurag Muddineni 1 collaboration

Neta Solomon 1 collaboration

Shahar Dotan 1 collaboration

Noam Pilpel 1 collaboration

Claudia Waskow 1 collaboration

Meora Feinmesser 1 collaboration

Peleg Rider 1 collaboration

Yaron Carmi 1 collaboration